A new study has delivered some of the most compelling evidence yet that vitamin D supplements might make a meaningful difference for children with autism spectrum disorder (ASD).
Published in BMC Pediatrics, this carefully designed study tackles a common question in autism care: Can vitamin D supplementation improve both brain inflammation and real-world behaviors in children with ASD? The answer, according to the researchers, is a cautious but encouraging “yes” — with some important caveats.
New Evidence Linking Vitamin D to Autism Improvement
Researchers at Kermanshah University conducted a rigorous double-blind, placebo-controlled trial that measured both biological changes in the blood and clinical improvements in behavior. The study followed 43 children aged 3-13 with ASD for 15 weeks, giving half a weight-based dose of vitamin D3 (up to 6,000 IU daily) and half a matching placebo. Critically, all participants started with vitamin D levels below 30 ng/mL.
The biological findings were striking: Children receiving vitamin D showed significant reductions in TNF-α, a key inflammatory molecule that’s been linked to autism symptoms. Even more intriguing, levels of IL-37—an anti-inflammatory molecule that’s paradoxically elevated in autism—also decreased, suggesting the brain’s inflammatory stress response was calming down.
The behavioral improvements were more subtle but real: Using a clinician-rated scale that measures real-world functioning, children in the vitamin D group showed modest but meaningful improvements in daily behaviors. While the changes weren’t dramatic enough to reach statistical significance when compared directly to placebo, the within-group improvements suggest something beneficial was happening.
“Our findings shed light on the possible beneficial effects of vitamin D in regulating pro-inflammatory and anti-inflammatory markers, including TNF-α, and IL-37, respectively, as well as alleviating the behavioral symptoms of children with ASD,” say researchers.
Vitamin D is a powerful regulator of immune function, brain development, and neurotransmitter production. The fact that this study documented both reduced inflammation and behavioral improvements provides “mechanistic plausibility”— the ability to see that something worked and a glimpse of how it may be working. The inflammatory changes align perfectly with emerging theories about autism involving immune dysfunction and neuroinflammation.
Study Limitations
The sample size was relatively small (43 children), and the behavioral improvements, while encouraging, didn’t reach the gold standard of statistical significance between groups. The study was also relatively short, lasting just 15 weeks — we don’t know about longer-term effects or safety. Additionally, all participants were from a single clinic in Iran, and the study only measured two inflammatory markers rather than the broader immune panels researchers would ideally want to see.
Conclusion
Vitamin D deficiency is common in children with ASD, and correcting deficiency is a safe, inexpensive way to support healthy inflammatory responses and help reduce an inflammatory stress response. While more research is needed, this study provides the strongest evidence yet that correcting deficiency might offer both biological and behavioral benefits.
